Gretchen Brewer
Clinical Trial Manager
I am a Clinical Trial Manager based in the Experimental Medicine and Rheumatology (EMR) group working on the TaILOR study. TaILOR is a pragmatic trial, aiming to study the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to traditional care pathways in people with inflammatory arthritis.
I originally joined NDORMS as a Clinical Study Administrator in 2019 supporting various research projects within the Centre for Osteoarthritis Pathogenesis Versus Arthritis at the Kennedy Institute. Prior to this, I worked as a Research Assistant at Rutgers University coordinating a study examining the role of oxidative stress in autism and as a Clinical Research Associate in the pharmaceutical industry.
Recent publications
-
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
Williams JAE. et al, (2022), Lancet rheumatol, 4, e725 - e737
-
Is Treating Painful Hand Osteoarthritis with Hormone Replacement Therapy Feasible? Primary Results from a Randomised Controlled Trial in Post-menopausal Women
Williams J. et al, (2022), Arthritis & rheumatology, 74, 3763 - 3765